UK's Mycofeast acquires New Zealand's Daisy Lab in biotech deal

What's the deal? UK-based MycofeastDealroom has a profile for this one. Try Dealroom → has acquired Auckland biotech startup Daisy LabDealroom has a profile for this one. Try Dealroom → for an undisclosed sum, the companies announced in October 2026.

What's the endgame? The acquisition brings Daisy Lab's New Zealand operations under Mycofeast's umbrella. Terms of the deal were not disclosed.

The signal: The cross-border tie-up points to continued consolidation in the precision fermentation and alternative biotech space, as companies combine capabilities across markets.

Read more: businessdesk.co.nz

Image credit: Generated with Gemini